Labels
Breast Cancers
(148)
Lung Cancers
(75)
Genitourinary Cancers
(73)
Gastrointestinal Cancers
(67)
Gynecological Cancers
(58)
Head and Neck Cancers
(50)
Cutaneous Cancers
(21)
Central Nervous System Cancers
(11)
Monday, 28 May 2012
The BEACON study (breast cancer outcomes with NKTR-102)
The BC Cancer Agency has designed a randomized controlled trial for patients with metastatic breast cancer. The trial seeks to uncover the effects of adding NKTR-102 once every 3 weeks to a patient's existing intravenous chemotherapy regimen.
More information on this trial can be found here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment